|
TMEM167B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6242562850266E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.26609997433513E-09 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
4.415800E-01 |
| Stage1-vs-Stage3 |
1.687550E-01 |
| Stage1-vs-Stage4 |
2.973400E-04 |
| Stage2-vs-Stage3 |
1.111630E-01 |
| Stage2-vs-Stage4 |
3.596600E-03 |
| Stage3-vs-Stage4 |
5.617500E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.64840000000033E-06 |
| Normal-vs-Asian |
3.33066907387547E-16 |
| Caucasian-vs-AfricanAmerican |
1.811360E-01 |
| Caucasian-vs-Asian |
3.031000E-01 |
| AfricanAmerican-vs-Asian |
1.470170E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
8.026000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.6242562850266E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62558855265615E-12 |
| Normal-vs-Age(81-100Yrs) |
1.440080E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.252800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.074800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.559800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.637600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.801800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.323600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.139400E-03 |
| Classical-VS-Follicular |
8.523300E-03 |
| Classical-VS-Other |
9.104000E-01 |
| Classical-VS-Normal |
1.6242562850266E-12 |
| Tall-VS-Follicular |
2.36019999999559E-05 |
| Tall-VS-Other |
4.360800E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
3.609600E-01 |
| Follicular-VS-Normal |
8.30049995403925E-09 |
| Other-VS-Normal |
3.987300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
2.173300E-04 |
|
|
